Teen, living with factor XIII A-subunit deficiency, seated with his clarinet in an auditorium

Manny has congenital factor XIII deficiency

Tretten® is the only recombinant therapy for congenital factor XIII A-subunit deficiency, a bleeding disorder affecting about 1 in every 1 to 3 million people

Molecule icon
Molecule icon

I would like more information about Tretten®

Learn more

Folder
Folder

I would like assistance with getting
and using Tretten®

Find help

Conversation bubbles
Conversation bubbles

I would like to talk with a Novo Nordisk Representative

Find a Rep